Dexcom (DXCM)
$440.50
5.39 (1.24%)
DXCM Stock Quote Delayed 30 Minutes
Previous Close
$436.02
Market Cap
38.80B
PE Ratio
-1,190.54
EPS
-0.37
Volume (Avg. Vol.)
1.07M
Day's Range
428.50 - 445.52
52-Week Range
138.28 - 439.49
Dividend & Yield
N/A (N/A)
DXCM Stock Predictions, Articles, and Dexcom News
3 Great Growth Stocks That Kept Climbing in This Tough Market
While many companies were unable to avoid the wrath of the coronavirus pandemic, these three companies stood out as big winners.
The 52-Week Highs You Never Heard About
The fear-mongering media had quite a few factors to scare investors with last Friday: the U.S.-China trade war, President Trump’s latest tweets, and the plummeting S&P 500. Underneath the big selloff, would you ever guess that plenty of stocks made new 52-week highs that very same day?
3 Big Stock Charts for Monday: Twitter, UnitedHealth Group and Philip Morris
The stock charts of UNH, TWTR and PM are poised to start the new trading week on the verge of big moves. Here are the levels to keep an eye on.
2 Internet of Things Stocks to Buy for the Connected Future
These Internet of Things stocks should be on your stocks to buy list as they have slipped under the radar and continue to present unique long-term opportunities in the IoT space.
DexCom Stock Skyrockets on Q2 Earnings Beat
DexCom (DXCM) stock was on the rise Thursday following the release of a strong earnings report for the second quarter of 2018.
5 MedTech Stocks That Perfectly Blend Healthcare and Technology
MedTech Stocks are hot, hot, hot. Here are five of the best to buy today for long-term growth.
This Is Not the End of the World for Fitbit Inc Stock
Another dip in quarterly sales and profits confirms the worst fears for Fitbit stock holders as Fitbit Inc just can't find its lane.
Fitbit for Kids? FIT Considering Smartwatch for Children
Fitbit (FIT) is reportedly working on a version of Fibit for kids, but the device is still in the early stages of development.
Fibit Inc Invests in Blood Glucose Monitoring Startup
The Fitbit investment in Sanos, a startup developing a coin-sized blood glucose monitor for diabetics, is proof that Fitbit has no intention of letting Apple dominate the health tracking market the same way it took over the smart watch market.
Fitbit Inc (NYSE:FIT) Stock Still Has A Lot of Work To Do
Fitbit stock hit an eight-month high before a recent pullback. But the "this time is different" story behind FIT stock isn't strong enough.
Why Fitbit Inc (FIT) Stock Is Rising on the Latest Ionic Update
Fitbit stock got another boost on news it inked a deal with Dexcom to bring CGM data for diabetics to the Fitbit Ionic smartwatch.
7 Health Care Equipment & Supplies Stocks to Sell Now
The overall ratings of 7 Health Care Equipment & Supplies stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
7 Health Care Equipment & Supplies Stocks to Sell Now
This week, the ratings of 7 Health Care Equipment & Supplies stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
Navellier Ratings
Powered by Portfolio GraderTotal Grade
A
